Trinity Biotech (TRIB) Asset Writedowns and Impairment (2021 - 2024)
Trinity Biotech's (TRIB) quarterly Asset Writedowns and Impairment came in at -$962000.0 in Q4 2024, down 231.72% year-on-year from $730314.1 in Q1 2024, and down 7.85% quarter-over-quarter from -$892000.0 in Q3 2024.
Trinity Biotech (TRIB) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends
Trinity Biotech has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting -$962000.0 for Q4 2024.
- Asset Writedowns and Impairment for Q4 2024 came in at -$962000.0, down 231.72% year-over-year; the trailing twelve-month figure through Dec 2024 was -$2.6 million (up 92.76% YoY), and the FY2025 annual result was $2.2 million, up 254.62% from the prior year.
- Asset Writedowns and Impairment came in at -$962000.0 for Q4 2024 at Trinity Biotech, down from -$892000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of -$290000.0 in Q4 2023 to a low of -$21.6 million in Q3 2023.
- The 4-year median for Asset Writedowns and Impairment is -$962000.0 (2024), against an average of -$4.3 million.
- Across the five-year window, Asset Writedowns and Impairment slumped 1983.82% in 2023 and soared 95.88% in 2024, its largest moves.
- Trinity Biotech's Asset Writedowns and Impairment stood at -$876000.0 in 2021, then tumbled by 246.12% to -$3.0 million in 2022, then surged by 90.44% to -$290000.0 in 2023, then sank by 231.72% to -$962000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at -$962000.0 (Q4 2024), -$892000.0 (Q3 2024), and -$446000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -962,000.00 |
| Dec 31, 2024 | -962,000.00 |
| Sep 30, 2024 | -892,000.00 |
| Sep 30, 2024 | -892,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Dec 31, 2023 | -290,000.00 |
| Dec 31, 2023 | -290,000.00 |
| Sep 30, 2023 | -21.63 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -10.82 Mn |
| Jun 30, 2023 | -10.82 Mn |
| Dec 31, 2022 | -3.03 Mn |
| Dec 31, 2022 | -3.03 Mn |
| Sep 30, 2022 | -2.29 Mn |
| Sep 30, 2022 | -2.29 Mn |
| Jun 30, 2022 | -519,000.00 |
| Jun 30, 2022 | -519,000.00 |
| Dec 31, 2021 | -876,000.00 |
| Dec 31, 2021 | -876,000.00 |